The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Leucid Bio
Research Funding - Leucid Bio (Inst)
Patents, Royalties, Other Intellectual Property - Leucid Bio (Inst)
A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC).
 
Sophie Papa
Honoraria - Amgen; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - MSD Oncology
 
Antonella Adami
Patents, Royalties, Other Intellectual Property - Leucid Bio (I)
 
Michael Metoudi
No Relationships to Disclose
 
Daniela Achkova
No Relationships to Disclose
 
May van Schalkwyk
No Relationships to Disclose
 
Ana Parente Pereira
No Relationships to Disclose
 
Leticia Bosshard-Carter
No Relationships to Disclose
 
Lynsey Whilding
No Relationships to Disclose
 
Sjoukie van der Stegen
No Relationships to Disclose
 
David Davies
No Relationships to Disclose
 
Farzin Farzaneh
No Relationships to Disclose
 
Teresa Guerrero Urbano
No Relationships to Disclose
 
Jean-Pierre Jeannon
No Relationships to Disclose
 
James F. Spicer
Stock and Other Ownership Interests - IGEA
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
 
John Maher
No Relationships to Disclose